R&D ‘Recoupment’ Data Demands To Inform Medicare Negotiation Are Unworkable, CMS Told

 
• By Cathy Kelly
  
CMS Advised To Accept Manufacturer Attestations About R&D Spending • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Market Access

More from Pink Sheet